{"id":"W4226113086","doi":"10.1016/j.annonc.2022.02.015","title":"6MO Pembrolizumab plus ipilimumab or placebo in previously untreated metastatic NSCLC with PD-L1 tumor proportion score ≥50%: KEYNOTE-598 3-year follow-up","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; St Mary's Hospital Centre","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001360238,0.0005669233,0.001848817,0.0003039832,0.000370388,0.0006748687,0.0004743397,0.0009068378,0.003279153],"category_scores_gemma":[0.0007901649,0.0002747715,0.002066809,0.0002992849,0.0003261244,0.001106325,0.0003258727,0.002020468,0.0006815994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005527359,"about_ca_system_score_gemma":0.0006018637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001392169,"about_ca_topic_score_gemma":0.003613128,"domain_scores_codex":[0.999543,0.0001302455,0.00003052838,0.00009492802,0.00004550871,0.0001559053],"domain_scores_gemma":[0.9996493,0.00008942766,0.00007841818,0.00003774268,0.00002336307,0.0001218044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8361313,0.01096347,0.0148993,0.0007339359,0.003647884,0.0002232679,0.0001106123,0.001361074,0.006435646,0.0001323189,0.003488944,0.1218722],"study_design_scores_gemma":[0.2735709,0.4620282,0.2407131,0.000298285,0.006724075,0.0004875331,0.0002009997,0.002303552,0.003542044,0.0005917717,0.009453782,0.00008566315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846549,0.008693311,0.0002761274,0.0003986598,0.0003464494,0.0004276713,0.001706045,0.00004980146,0.003447034],"genre_scores_gemma":[0.9898856,0.003330723,0.0003046483,0.0006924377,0.0002389407,0.0004190759,0.002068383,0.00001067041,0.003049557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003279153,"threshold_uncertainty_score":0.01096988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07065250765017408,"score_gpt":0.349824965715346,"score_spread":0.2791724580651719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}